Travel hurdle over made-in-India vaccine: What SII CEO said on Covishield-EU row

Published on Jun 28, 2021 03:42 PM IST
Copy Link

It might be tough for Indians to travel to Europe. The European Union has excluded Covishield from its green pass, a certificate now to be issued for the movement of travelers across member nations. Covishield is one of India’s primary vaccines and many Indians had raised concerns around travel to Europe. The CEO of Serum Institute of India, Adar Poonawalla, took to twitter to address the issue and said that he has taken it up at the highest levels. SII is the manufacturer of the Oxford Astrazeneca vaccine in India. However, Oxford-Astrazeneca’s vaccine manufactured in the UK and other parts of Europe has the approval of the EMA.

Story Saved
Saved Articles
My Reads
Sign out
New Delhi 0C
Thursday, May 26, 2022